CD2BP2
CD2 antigen cytoplasmic tail-binding protein 2
Also known as: CD2B2_HUMAN, LIN1, PPP1R59, Snu40, U5-52K
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O95400
- Gene
- CD2BP2
- Ensembl
- ENSG00000169217
- Chromosome
- 16
- Canonical length
- 341 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nuclear speckles,Cytosol
OverviewNCBI Gene
This gene encodes a bi-functional protein. In the cytoplasm, the encoded protein binds the cytoplasmic tail of human surface antigen CD2 via its C-terminal GYF domain, and regulate CD2-triggered T lymphocyte activation. In the nucleus, this protein is a component of the U5 small nuclear ribonucleoprotein complex and is involved in RNA splicing. A pseudogene has been identified on chromosome 7. Alternative splicing results in multiple transcript variants but their biological validity has not been determined. [provided by RefSeq, Nov 2008]
Canonical amino-acid sequenceUniProt
341 residues, UniProt reviewed canonical sequence.
>O95400|CD2BP2
1 MPKRKVTFQG VGDEEDEDEI IVPKKKLVDP VAGSGGPGSR FKGKHSLDSD EEEDDDDGGS
61 SKYDILASED VEGQEAATLP SEGGVRITPF NLQEEMEEGH FDADGNYFLN RDAQIRDSWL
121 DNIDWVKIRE RPPGQRQASD SEEEDSLGQT SMSAQALLEG LLELLLPRET VAGALRRLGA
181 RGGGKGRKGP GQPSSPQRLD RLSGLADQMV ARGNLGVYQE TRERLAMRLK GLGCQTLGPH
241 NPTPPPSLDM FAEELAEEEL ETPTPTQRGE AESRGDGLVD VMWEYKWENT GDAELYGPFT
301 SAQMQTWVSE GYFPDGVYCR KLDPPGGQFY NSKRIDFDLY TLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CD2BP2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.51
- Highest tissue expression
- 47 nTPM
Expression across tissuesHPA
Tissue
- adrenal gland: 47 nTPM
- spleen: 44 nTPM
- skeletal muscle: 44 nTPM
- tonsil: 41 nTPM
- thyroid gland: 41 nTPM
- pituitary gland: 40 nTPM
Single-cell type
- esophageal apical cells: 124 nCPM
- megakaryocytes: 118 nCPM
- syncytiotrophoblasts: 111 nCPM
- decidual stromal cells: 86 nCPM
- hofbauer cells: 86 nCPM
- esophageal suprabasal cells: 76 nCPM
Immune cell
- neutrophil: 122 nTPM
- eosinophil: 117 nTPM
- basophil: 108 nTPM
- non-classical monocyte: 103 nTPM
- naive B-cell: 98 nTPM
- T-reg: 95 nTPM
Brain region
- white matter: 42 nTPM
- medulla oblongata: 42 nTPM
- hypothalamus: 41 nTPM
- cerebral cortex: 41 nTPM
- midbrain: 39 nTPM
- thalamus: 38 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.04
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.56
- DepMap mean gene effect
- -0.27
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- GYF domain
- GYF-like domain superfamily
- GYF domain
- CD2 antigen cytoplasmic tail-binding protein 2/Lin1
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CD2BP2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CD2BP2 as an antibody target. Whether an autoantibody or antibody against CD2BP2 could matter depends on whether native CD2BP2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CD2BP2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CD2BP2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...